73
Views
179
CrossRef citations to date
0
Altmetric
Original Article

1,25-Dihydroxyvitamin D3 Attenuates of Expression of Experimental Murine Lupus of MRL/1 Mice

, &
Pages 143-148 | Received 27 Sep 1991, Accepted 11 Dec 1991, Published online: 07 Jul 2009

References

  • Lemire J. M., Adams J. S., Sakai R., Jordan S. C. la,25-Dihydroxy-vitamin D, suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984; 74: 657–661
  • Manolagas S. C., Provvedini D. M., Tsoukas C. D. Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol 1985; 43: 113–122
  • Rigby W. FC. The immunobiology of vitamin D. Immunmol Today 1988; 9: 54–58
  • Rigby W. F. C., Waugh M., Grozrano R. F. Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-Dihydroxyvitamin D3. Blood 1990; 76: 189–197
  • Lemire J. M., Adams J. S., Kermani-Arab V., Bakke A., Sakai R., Jordan S. C. 1,25-Dihydroxyvitamin D3 suppresses human helper/inducer lymphocyte activity in vitro. J Immunol 1985; 134: 3032–3035
  • Provvedini D. M., Manolagas S. C. 1,25-Dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J Clin Endocrinol Metab 1989; 68: 774–779
  • Lemire J. M., Archer D. C. 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 1991; 87: 1103–1107
  • Systemic Lupus Erythematosus, R. G. Lahita. John Wiley & Sons. 1987; 121–202
  • Andrews B. S., Eisenberg R. S., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978; 148: 1198–1215
  • Theofilopoulos A. N., Eisenberg R. S., Bourdon M., Crowell J. S., Dixon F. J. Distribution of lymphocytes identified by surface markers in murine strains with SLE-like syndromes. J Exp Med 1979; 149: 516–534
  • Gilkeson G. S., Grudier J. P., Pisetsky D. S. The antibody response of normal mice to immunization with single-stranded DNA of various species origin. Clin Immunol Immunopath 1989; 51: 362–371
  • Rigby W. F. C., Shen L., Ball E. D., Guyre P. M., Fanger M. W. Differentiation of a human monocytic cell line by 1,25-Dihydroxyvitamin D3 (calcitriol): A morphologic, phenotypic, and functional analysis. Blood 1984; 64: 1110–1115
  • Smith E. L., Pincus S. H., Donovan L., Holick M. F. A novel approach for the evaluation and treatment of psoriasis. J Am Acad Dermatol 1988; 19: 516–528
  • Morimoto S., Yoshikawa K. Psoriasis and vitamin D3. A review of our experience. Arch Dermatol 1989; 125: 231–234
  • Honma Y., Hozumi M., Abe E., Konno K., Fukushima M., Hata S., et al. 1,25-Dihydroxyvitamin D3 prolongs survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sei USA 1983; 80: 201–204
  • Kanauchi H., Furukawa F., Imamura S. Characterization of cutaneous infiltrates in MRL/Ipr mice monitored from onset to the full development of lupus erythematosus-Iike skin lesions. J invest Dermatol 1991; 96: 478–483
  • Takahashi S., Nose M., Sasaki J., Yamamoto T., Kyogoku M. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J Immunol 1991; 147: 515–519
  • Abe J., Takita Y., Nakano T., Miyaura C., Suda T., Nishii Y. A synthetic analogue of vitamin D3, 22-OXA-1,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice. Endocrinology 1989; 124: 2645–2647
  • Zhou J. Y., Norman A. W., Chen D. L., Gun G. W., Uskokovic M., Koeffler H. P. 1,25-Dihydroxy-16-ene-23-yne-vitamin D, prolongs survival time of leukemic mice. Proc Natl Acad Sci USA 1991; 87: 3929–3930
  • Meehan M. A., Kerman R. H., Lemire J. M. 1,25-Dihydroxyvitamin D3 énhances the generation of non-specific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR. Cell Immunol
  • Mountz J. D., Smith H. R., Wilder R. L., Reeves J. P., Steinberg A. D. CS-A therapy in MRL-lpr/lpr mice; amelioration of immunopathology despite autoantibody production. J Immunol 1987; 138: 157–163

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.